Thornberry Nancy sold DNLI
September 2, 2026 · Form 4 insider transaction
Thornberry Nancy sold 615 shares of Denali Therapeutics Inc. at $23.74 per share, a transaction worth $14.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted June 3, 2026.; The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.59 to $23.85 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.; Includes 6,408 Unvested RSUs.